Mineralys Therapeutics Shares Are Trading Higher After Goldman Sachs Initiated Coverage on the Stock With a Buy Rating and Announced a Price Target of $30
在高盛以買入評級啓動對該股的保險並宣佈目標股價爲30美元之後,Mineralys Therapeutics的股價走高
Mineralys Therapeutics Shares Are Trading Higher After Goldman Sachs Initiated Coverage on the Stock With a Buy Rating and Announced a Price Target of $30
在高盛以買入評級啓動對該股的保險並宣佈目標股價爲30美元之後,Mineralys Therapeutics的股價走高
使用瀏覽器的分享功能,分享給你的好友吧